(function(){var loadHandler=window['sl_{EC00A760-FAC2-48CD-8603-FA3C7FB92E6B}'];loadHandler&&loadHandler(5, '<div id="spr0_36526bf"><div id="spr1_36526bf" class="kern slide"><img id="img8_36526bf" src="data/img9.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_36526bf" class="kern slide"><img id="img0_36526bf" src="data/img10.png" width="1280" height="720" alt=""/><img id="img1_36526bf" src="data/img10.png" width="1279.68" height="720" alt=""/><div id="spr3_36526bf" style="left:-0px;"><img id="img2_36526bf" src="data/img16.png" width="423.75" height="720.75" alt=""/></div><div id="spr4_36526bf" style="left:-0.001px;top:1.064px;"><img id="img3_36526bf" src="data/img17.png" width="423.75" height="720.75" alt=""/></div><div id="spr5_36526bf" style="left:-0.001px;top:457.324px;"><img id="img4_36526bf" src="data/img18.png" width="423.75" height="263.25" alt=""/></div><div id="spr6_36526bf" style="left:-105.416px;top:53.689px;"><img id="img5_36526bf" src="data/img19.png" width="372.75" height="439.5" alt=""/></div><div id="spr7_36526bf" style="left:-0.001px;top:-1.065px;"><img id="img6_36526bf" src="data/img20.png" width="423.75" height="720" alt=""/></div><div id="spr8_36526bf" style="left:18px;top:61.612px;"><div style="width:0px;"><span id="txt0_36526bf" data-width="346.671875" style="left:18.013px;top:245.605px;">Pharmacogenomics</span></div><div style="width:0px;"><span id="txt1_36526bf" data-width="68.363281" style="left:290.48px;top:293.125px;">PGx</span></div></div><div id="spr9_36526bf" style="left:505.014px;top:68.187px;"><div style="width:0px;"><span id="txt2_36526bf" class="nokern relpos" dir="auto" style="left:9.6px;top:33.371px;">•</span> <span id="txt3_36526bf" class="relpos" data-width="591.264343" style="left:23.33px;top:29.239px;">The term CDx first appeared in 2006, with various</span></div><div style="width:0px;"><span id="txt4_36526bf" data-width="512.631531" style="left:9.6px;top:60.919px;">other terms such as pharmacogenetics and</span></div><div style="width:0px;"><span id="txt5_36526bf" data-width="509.595062" style="left:9.6px;top:92.599px;">pharmacodiagnostics appearing until then.</span></div><div style="width:0px;"><span id="txt6_36526bf" class="nokern relpos" dir="auto" style="left:9.6px;top:140.976px;">•</span> <span id="txt7_36526bf" class="relpos" data-width="575.867188" style="left:23.33px;top:136.843px;">X-evolving landscape Dx, Px, Precision Medicine,</span></div><div style="width:0px;"><span id="txt8_36526bf" data-width="492.407562" style="left:9.6px;top:169.293px;">Personalised Medicine, Theranostics, etc.</span></div><div style="width:0px;"><span id="txt9_36526bf" class="nokern relpos" dir="auto" style="left:9.6px;top:217.669px;">•</span> <span id="txt10_36526bf" class="relpos" data-width="517.931030" style="left:23.33px;top:213.537px;">Evolving paradigm from ‘one-size-fits-all’ to</span></div><div style="width:0px;"><span id="txt11_36526bf" data-width="665.170593" style="left:9.6px;top:245.986px;">personalized therapies (Rx) driving improved outcomes.</span></div><div style="width:0px;"><span id="txt12_36526bf" class="nokern relpos" dir="auto" style="left:9.6px;top:294.362px;">•</span> <span id="txt13_36526bf" class="relpos" data-width="118.622398" style="left:23.33px;top:290.23px;">Oncology </span> <span id="txt14_36526bf" class="relpos" data-width="132.171875" style="left:23.324px;top:290.23px;">(still main) </span> <span id="txt15_36526bf" class="relpos" data-width="342.747406" style="left:23.317px;top:290.23px;">driver for precision medicine</span></div><div style="width:0px;"><span id="txt16_36526bf" data-width="646.307312" style="left:9.6px;top:322.679px;">(PM). While oncology will remain the therapeutic area</span></div><div style="width:0px;"><span id="txt17_36526bf" data-width="663.867188" style="left:9.6px;top:354.359px;">at the forefront of CDx for the foreseeable future based</span></div><div style="width:0px;"><span id="txt18_36526bf" data-width="634.662781" style="left:9.6px;top:386.039px;">on currently approved drugs, other therapeutic areas</span></div><div style="width:0px;"><span id="txt19_36526bf" data-width="300.036469" style="left:9.6px;top:417.719px;">are beginning to emerge.</span></div><div style="width:0px;"><span id="txt20_36526bf" class="nokern relpos" dir="auto" style="left:9.6px;top:466.095px;">•</span> <span id="txt21_36526bf" class="relpos" data-width="249.576828" style="left:23.33px;top:461.963px;">EGFR, HER2, and ALK</span></div></div><div id="spr10_36526bf" aria-label="DNA" role="group" style="left:116px;top:56.583px;"><div id="spr11_36526bf"><img id="img7_36526bf" src="data/img21.svg#svgView(preserveAspectRatio(none);viewBox(0 0 96 96))" width="78.667" height="78.667" alt=""/></div></div><div id="spr12_36526bf" style="left:106px;top:650.492px;"><div style="width:0px;"><span id="txt22_36526bf" class="nokern" data-width="1063.728394" style="left:9.6px;top:5.016px;">Papadopoulos et al. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies. Nat Biotechnol. 2006 Aug;24(8):985-95. doi: 10.1038/nbt1234</span></div><div style="width:0px;"><span id="txt23_36526bf" class="nokern" data-width="952.855957" style="left:9.6px;top:27.393px;">Tsimberidou et al.. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 2020 Jun;86:102019. doi: 10.1016/j.ctrv.2020.102019.</span></div></div></div></div>', '{"s":[]}');})();